TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Jenving Clinical Trial Services AB
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
795
|
772 | |
| Financial expenses |
0
|
1 | |
| Earnings before taxes |
134
|
246 | |
| EBITDA |
128
|
229 | |
| Total assets |
1,183
|
1,206 | |
| Current assets |
839
|
1,014 | |
| Current liabilities |
137
|
43 | |
| Equity capital |
965
|
1,090 | |
| - share capital |
34
|
33 | |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
81.6%
|
90.4% | |
| Turnover per employee |
795
|
772 | |
| Profit as a percentage of turnover |
16.9%
|
31.9% | |
| Return on assets (ROA) |
11.3%
|
20.5% | |
| Current ratio |
612.4%
|
2358.1% | |
| Return on equity (ROE) |
13.9%
|
22.6% | |
| Change turnover |
19
|
7 | |
| Change turnover % |
22%
|
2%
|
1% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.